Cargando…
Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis—A Phase I Study
Bone marrow derived mesenchymal stromal cells (BM-MSCs) have emerged as a possible new therapy for Multiple Sclerosis (MS), however studies regarding efficacy and in vivo immune response have been limited and inconclusive. We conducted a phase I clinical study assessing safety and clinical and perip...
Autores principales: | Iacobaeus, Ellen, Kadri, Nadir, Lefsihane, Katia, Boberg, Erik, Gavin, Caroline, Törnqvist Andrén, Anton, Lilja, Anders, Brundin, Lou, Blanc, Katarina Le |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947442/ https://www.ncbi.nlm.nih.gov/pubmed/31810187 http://dx.doi.org/10.3390/jcm8122102 |
Ejemplares similares
-
Current perspectives on mesenchymal stromal cell therapy for graft versus host disease
por: Kadri, Nadir, et al.
Publicado: (2023) -
The Complement System Is Essential for the Phagocytosis of Mesenchymal Stromal Cells by Monocytes
por: Gavin, Caroline, et al.
Publicado: (2019) -
Tissue immune profiles supporting response to mesenchymal stromal cell therapy in acute graft-versus-host disease—a gut feeling
por: Gavin, Caroline, et al.
Publicado: (2019) -
Cognitive impairments correlate with increased central nervous system immune activation after allogeneic haematopoietic stem cell transplantation
por: Boberg, Erik, et al.
Publicado: (2023) -
Dynamic Changes in Brain Mesenchymal Perivascular Cells Associate with Multiple Sclerosis Disease Duration, Active Inflammation, and Demyelination
por: Iacobaeus, Ellen, et al.
Publicado: (2017)